ロード中...
Targeting inflammation for the treatment of alcoholic liver disease(),()
Alcoholic liver disease (ALD) is a leading cause of chronic liver disease with a wide spectrum of manifestations including simple steatosis to steatohepatitis, cirrhosis, and hepatocellular carcinoma. Liver injury in ALD is caused by chronic inflammation, which has been actively investigated as a th...
保存先:
| 出版年: | Pharmacol Ther |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5677537/ https://ncbi.nlm.nih.gov/pubmed/28642119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2017.06.007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|